Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALLO
PBYI
Add up to 3 more stocks
ALLO
Allogene Therapeutics, Inc.
-1.67%
$1.48-0.02Delayed quote: Oct 6, 2026, 3:05 PM EDT
Market Cap
$509.10M
52W Range
$1.04 - $4.46
PBYI
Puma Biotechnology, Inc.
-0.78%
$9.60-0.07Delayed quote: Oct 6, 2026, 3:05 PM EDT
Market Cap
$488.38M
52W Range
$4.58 - $10.10
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 18.59 |
| Forward P/E | N/A | 25.25 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.17 | 3.53 |
| P/S Ratio | 109.72 | 2.11 |
| P/FCF Ratio | N/A | 11.89 |
| EV/EBITDA | N/A | 10.52 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 74.8% |
| Operating Margin | 0.0% | 13.2% |
| Net Margin | -3566.7% | 11.6% |
| ROE | -37.9% | 19.3% |
| ROA | -30.1% | 13.9% |
| ROIC | -34.8% | 18.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 10.72 | 2.91 |
| Quick Ratio | 10.72 | 2.64 |
| Debt/Equity | 0.16 | 0.03 |
| Interest Coverage | -192.50 | 5.63 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.